Colgate-Palmolive’s CEO noted that the company hit an “exciting milestone,” but it wasn’t enough to lift the stock premarket.

Colgate-Palmolive reported stable earnings for Q4 2024, beating EPS estimates but just missing revenue expectations.

CL's Q4 results show continued gains from volume and pricing, leading to organic sales growth in five of the six divisions.

Q4 2024 Management View CEO Noel Wallace highlighted net sales of $20 billion in 2024, achieving this milestone one year ...

Colgate-Palmolive Co. shares are down 3.8% in premarket trades despite the toothpaste and toothbrush giant reporting better-than-expected fourth-quarter profit and hitting a full-year revenue ...

Colgate-Palmolive (NYSE:CL – Get Free Report)‘s stock had its “outperform” rating reaffirmed by research analysts at Raymond ...

Shares of Colgate-Palmolive (NYSE: CL) pulled back today after the household products giant missed the mark on the top line ...

Net sales decreased 0.1%; Organic sales* increased 4.3%, including a 0.5% negative impact from lower private label pet volume GAAP EPS increased 3% to $0.90; Base Business EPS* increased 5% to $0.91 ...

Colgate-Palmolive maintained its leadership position in oral care, with a 41.4% global market share in toothpaste and a 32.2% ...